Diagnostic disclosure of Alzheimer's disease in Brazil: a national survey of specialized physicians
Authors:
- Vitor Santos de SouzaVSVitor Santos de Souza
- Sofia Brunchport GuazzelliSGSofia Brunchport Guazzelli
- Leonardo Cardoso CruzLCLeonardo Cardoso Cruz
- Elisa de Paula França ResendeERElisa de Paula França Resende
- Leonardo Cruz de SouzaLSLeonardo Cruz de Souza
- Maira Tonidandel BarbosaMBMaira Tonidandel Barbosa
- Paulo CaramelliPCPaulo Caramelli
Open Access
- 1 October 2023
- journal article
- research article
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 81 (10) , 905-912
Abstract
Background: The diagnosis of Alzheimer's disease (AD) can bring financial and emotional consequences to patients and caregivers. Whether or not the diagnosis should be disclosed to patients is a matter of debate amongst physicians and can be influenced by culture and experience. Objective: To investigate the current practice of physicians who attend and treat patients with dementia in Brazil regarding the disclosure of dementia diagnosis and compare the practice with what has been performed 15 years ago in the country. Methods: Data were evaluated using an electronic questionnaire. The questions used to carry out this research were similar to the questions of the study carried out 15 years ago 9. The form was sent to the Brazilian Academy of Neurology, the Brazilian Association of Geriatrics and Gerontology, and the Brazilian Association of Psychiatry, which forwarded it to their members. Analyses were conducted through non-parametric statistical tests, with a post-hoc assessment. Results: 397 physicians responded to the survey, of which 231 are neurologists, 124 geriatricians, 29 psychiatrists and 13 from other specialties. The mean age was 45.2 years. The majority (66.7%) of the physicians reveal the diagnosis of AD always or usually. The youngest group of neurologists were more likely to disclose the diagnosis than the oldest group with a significant difference between them. In comparison to the 2008 Brazilian study, the percentage of physicians who always or usually disclose the diagnosis has risen by 22%. On the other hand, 12.3% of the physicians rarely or never disclose the diagnosis, in comparison to 25,3% in 2008. The main reasons for not disclosing the diagnosis concern the patients' mental health. Conclusion: Advances in dementia knowledge and biomarkers availability probably explain the increase in the rate of disclosure. The main challenge is to reconcile the autonomy of affected individuals, mental health issues after the diagnosis and the family member's opinion.Keywords
This publication has 10 references indexed in Scilit:
- Diagnóstico da doença de Alzheimer: recomendações do Departamento Científico de Neurologia Cognitiva e do Envelhecimento da Academia Brasileira de NeurologiaDementia & Neuropsychologia, 2022
- Advances in the development of new biomarkers for Alzheimer’s diseaseTranslational Neurodegeneration, 2022
- Is Brazil ready for the expected increase in dementia prevalence?Cadernos de Saude Publica, 2021
- Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016The Lancet Neurology, 2019
- Depression associated with dementiaZeitschrift für Gerontologie und Geriatrie, 2015
- Disclosing the Truth: A Dilemma between Instilling Hope and Respecting Patient Autonomy in Everyday Clinical PracticeGlobal Journal of Health Science, 2013
- Depression as a risk factor or prodromal feature for dementia? Findings in a population-based sample of Swedish twins.Psychology and Aging, 2009
- O relatório Flexner: para o bem e para o malRevista Brasileira de Educação Médica, 2008
- A transição da estrutura etária da população brasileira na primeira metade do século XXICadernos de Saude Publica, 2008
- Alzheimer's disease diagnosis disclosure in Brazil: a survey of specialized physicians' current practice and attitudesInternational Psychogeriatrics, 2007